Publications found:
705
Sort by:
Alternative Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others), By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others), By End Users (Hospitals and Clinics, Cancer and Radiation Therapy Center, Home Care, Others), By Region & Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Alternative Cancer Therapeutics Market was valued at USD 15.65 billion in 2024 and is expected to reach USD 26.94 billion by 2030 with a CAGR of 9.62% during the forecast perio...
August 2025
188 pages
Chemotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Alkylating Agents, Anti-metabolites, Anti-Tumor Antibiotics, Hormones, Monoclonal Antibodies, Others), By Indication (Oncology/Cancer, Bone Marrow Diseases, Immune System Disorders, Others), By Dosage Form (Capsule, Tablets, Injections, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals, Specialty Clinics, Others), By Region & Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Chemotherapy Market was valued at USD 8.26 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.51% through 2030. Cancer, as...
August 2025
180 pages
Asia Pacific Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Market Size & Trends The Asia Pacific oncology based molecular diagnostics market size was estimated at USD 822.5 million in 2024 and is projected to reach USD 1,560.75 million by 2033, growing at a C...
August 2025
136 pages
Brachytherapy Market Report by Service Type (History and Physical Report, Discharge Summary, Operative Note or Report, Consultation Report, and Others (Pathology Report, Radiology Report, etc.)), Technology (EMR/EHR, PACS, RIS, SRT, and Others), Mode of Procurement (Outsourcing, Offshoring, Both), End-User (Hospitals, Clinics, Clinical Laboratories, Academic Medical Centers, and Others), and Region 2025-2033
US$ 3,999.00
The global brachytherapy market size reached USD 888.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,215.9 Million by 2033, exhibiting a growth rate (CAGR) of 3.55% d...
August 2025
149 pages
Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2025-2033
US$ 3,999.00
The global glioblastoma multiforme treatment market size reached USD 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.1 Billion by 2033, exhibiting a growth rate (CA...
August 2025
138 pages
Oncology Biosimilars Market Report by Drug Type (Monoclonal Antibody, Immunomodulators, G-CSF, Hematopoietic Agents, and Others), Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Kidney Cancer, Stomach Cancer, Brain Cancer, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2025-2033
US$ 3,999.00
The global oncology biosimilars market size reached USD 5.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 35.2 Billion by 2033, exhibiting a growth rate (CAGR) of 21.15...
August 2025
140 pages
Multiple Myeloma Drugs Market Size, Share, Trends and Forecast by Therapy, Drug Type, End User, Distribution Channel, and Region, 2025-2033
US$ 3,999.00
The global multiple myeloma drugs market size was valued at USD 23.46 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 36.86 Billion by 2033, exhibiting a CAGR of 4.89%...
August 2025
121 pages
Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Oncology Based Molecular Diagnostics Market The global oncology based molecular diagnostics market size was estimated at USD 3.75 b...
July 2025
136 pages
Oncology Based In-vivo CRO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Indication (Blood Cancer, Solid Tumor), By Model (Syngeneic Model, Patient Derived Xenograft, Xenograft), By Region & Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Oncology Based In-vivo CRO Market was valued at USD 1.24 billion in 2024 and is projected to grow at a CAGR of 8.29% through 2030. This dynamic sector plays a critical role...
July 2025
180 pages
United States Herceptin Market By Product (Biologic, Biosimilar), By Application (Breast Cancer, Stomach/Gastric Cancer, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Market Overview The United States Herceptin Market was valued at USD 1.32 billion in 2024 and is projected to reach USD 1.74 billion by 2030, growing at a CAGR of 4.66%. The market is advancing steadi...
July 2025
82 pages
Hemato Oncology Testing Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Services), By Cancer (Leukemia, Lymphoma), By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Hemato Oncology Testing Market The global hemato oncology testing market size was estimated at USD 3.60 billion in 2024 and is proj...
July 2025
120 pages
Erleada Market Size, Share & Trends Analysis Report By Type (Branded, Generic), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days Erleada Market The global erleada market size was estimated at USD 2,999 million in 2024 and is projected to reach USD 6,166 millio...
July 2025
150 pages
Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days Clinical Oncology Next Generation Sequencing Market The global clinical oncology next generation sequencing market size was estimat...
July 2025
125 pages
Circulating Tumor Cells Market Size, Share, and Analysis, By Technology (Immunomagnetic Enrichment, Microfluidics, Dielectrophoresis, Others), By Application (Cancer Detection, Drug Development, Research, Prognostics), By End-User (Hospitals, Research Institutes, Pharma Companies, Biotech Firms), By Region … Forecast 2025–2035
US$ 4,950.00
From 2025 to 2035, the Circulating Tumor Cells Market is expected to register a CAGR of 8.8%. Adoption accelerates as stakeholders seek higher performance, lower lifecycle costs, and compliance with t...
July 2025
656 pages
AI in Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others), By Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, Others), By Region & Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global AI in Oncology Market was valued at USD 701.08 Million in 2024 and is projected to grow at a CAGR of 9.43% through 2030. The market is gaining strong momentum due to the inc...
June 2025
172 pages
Africa Anticancer Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, Immunotherapy Drugs, Gene Therapy Drugs, Radiopharmaceuticals, and Others), Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostrate Cancer, and Others), Dosage Form (Tablet and Capsule, Injectable, and Liquid), Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Gene Therapy, Radiopharmaceutical Therapy, and Others), Sector (Private and Public), and Country
US$ 3,450.00
The Africa anticancer drugs market is expected to reach US$ 3.23 billion by 2031 from US$ 1.81 billion in 2024. The market is estimated to grow with a CAGR of 8.8% from 2025 to 2031. The Africa antica...
June 2025
315 pages
Global TROP2 Antibody Market & Clinical Trials Insight 2029
US$ 3,000.00
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Global TROP2 Antibody Market & Clinical Trials Insight 2029 Report Offering:Global TROP2...
August 2024
200 pages
Brazil Cancer Drugs Clinical Trials Insight 2024
US$ 3,300.00
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Brazil Cancer Drugs Clinical Trials Insight 2024 Report Offering:Brazil Clinical Trials M...
August 2024
-
Turkey Cancer Drugs Clinical Trials Insight 2024
US$ 3,300.00
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Turkey Cancer Drugs Clinical Trials Insight 2024 Report Offering:Turkey Clinical Trials M...
July 2024
500 pages
